Literature DB >> 21083074

Assessing the matrix effects of hemolyzed samples in bioanalysis.

Nicola C Hughes1, Navgeet Bajaj, Juan Fan, Ernest Y K Wong.   

Abstract

Validation of LC-MS/MS assays includes an assessment of matrix effects. Hemolysis effect, a special type of matrix effect, can also have an impact on analyte quantitation. In situations where the hemolysis effect is marginal, this can be resolved simply by dilution of hemolyzed samples with plasma prior to analysis. However, in some cases, the impact can be so dramatic that analytes are completely immeasurable. In such situations, modification to the bioanalytical method will be required, including, but not limited to, adjusting the chromatographic conditions to separate interferences present in hemolyzed samples; additional sample clean-up techniques such as protein precipitation in combination with SPE or a change in extraction technique such as from SPE to a liquid-liquid extraction method. Here, we report examples from four bioanalytical methods, where the presence of hemolyzed blood in plasma was found to have an impact on analyte quantitation and a description of the solutions adopted to resolve this are provided.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21083074     DOI: 10.4155/bio.09.91

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  4 in total

1.  Utilizing Internal Standard Responses to Assess Risk on Reporting Bioanalytical Results from Hemolyzed Samples.

Authors:  Eliza N Fung; Anne-Françoise Aubry; Alban Allentoff; Qin C Ji
Journal:  AAPS J       Date:  2015-05-15       Impact factor: 4.009

2.  Adding value to antiretroviral proficiency testing.

Authors:  Robin DiFrancesco; Charlene R Taylor; Susan L Rosenkranz; Kelly M Tooley; Poonam G Pande; Suzanne M Siminski; Richard W Jenny; Gene D Morse
Journal:  Bioanalysis       Date:  2014-10       Impact factor: 2.681

3.  New UPLC-MS/MS assay for the determination of tamoxifen and its metabolites in human plasma, application to patients.

Authors:  Christine Bobin-Dubigeon; Mario Campone; Elsa Rossignol; Estelle Salaun; Marie-Bernadette Amiand; Jean-Marie Bard
Journal:  Future Sci OA       Date:  2019-03-22

4.  Optimization, validation and initial clinical implications of a Luminex-based immunoassay for the quantification of Fragile X Protein from dried blood spots.

Authors:  Anna E Boggs; Lauren M Schmitt; Richard D McLane; Tatyana Adayev; Giuseppe LaFauci; Paul S Horn; Kelli C Dominick; Christina Gross; Craig A Erickson
Journal:  Sci Rep       Date:  2022-04-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.